Physician profile
Ping Xu
NPI 1255885216
$1,166.50
in general payments reported to CMS, 2019-2025
16 companies · $605 in 2025
The $605 reported for 2025 was more than what 76% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $51.87 · 2024: $247 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $244.98 | 2021-2025 | Xtampza, Belbuca |
| Averitas Pharma INC. | $198.09 | 2024-2025 | Qutenza |
| Globus Medical, INC. | $129.99 | 2025 | Vyrsa V1 |
| Scilex Pharmaceuticals INC. | $126.42 | 2021 | |
| Boston Scientific Corporation | $114.46 | 2025 | Intracept |
| Abbvie INC. | $92.56 | 2024-2025 | |
| Abbott Laboratories | $62.85 | 2024-2025 | Proclaim, Eterna |
| Almatica Pharma LLC | $52.65 | 2021 | |
| Grt US Holding, INC. | $39.14 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.19 | 2024 | |
| Hikma Pharmaceuticals USA | $18.50 | 2021 | |
| Ibsa Pharma INC. | $14.24 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.06 | 2021 | |
| Nalu Medical, INC. | $13.84 | 2024 | Nalu Neurostimulation System |
| Pfizer INC. | $12.14 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ping Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.